Navigation Links
CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital
Date:12/17/2009

SAN DIEGO, Dec. 17 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN) announced today that it has been notified of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) to purchase up to four million shares of CareFusion common stock, representing approximately 1.8 percent of the shares of common stock outstanding. TRC's offer price of $23.50 per share is 4.62 percent below the share closing price of CareFusion common stock on Dec. 14, 2009, the last full trading day prior to the offer. CareFusion also noted that the offer is subject to a number of conditions, including the right to terminate in the event of a decrease in the market price of CareFusion shares. TRC has made numerous similar, unsolicited mini-tender offers for shares of other companies in the past.

CareFusion strongly recommends against shareholders tendering their shares in response to TRC's unsolicited mini-tender offer. Mini-tender offers, such as this one, avoid many of the investor protections afforded to larger tender offers, including the filing of disclosure and other tender offer documents with the Securities and Exchange Commission (SEC) and other procedures mandated by U.S. securities laws. CareFusion is in no way associated with TRC, its mini-tender offer or the offer documentation.

The SEC has issued an investor advisory regarding mini-tender offers, noting that in making the offers at below-market prices "bidders are hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price." Investors are urged to consult with their brokers or financial advisors on such matters. The SEC advisory may be found on the SEC web site, at www.sec.gov/investor/pubs/minitend.htm.

CareFusion urges shareholders to obtain current market quotations for their shares of common stock, to consult with their financial advisors and to exercise caution with respect to this offer. The company advises shareholders who already have tendered that they may withdraw their common shares by providing the written notice described in the TRC offering documents prior to the expiration of the offer, currently scheduled for 12:01 a.m. EST on Thursday, Jan. 14, 2010.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilators, ChloraPrep® for infection prevention, MedMined(TM) services for infection surveillance, NeuroCare neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE CareFusion Corporation


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantros Acquires MediQual(TM) From CareFusion Corporation
2. New Medical Technology Company CareFusion Spins Off From Cardinal Health, Begins Trading on NYSE
3. Cardinal Health Completes Spinoff of CareFusion Corp.
4. CareFusion Corp to be Included in S&P 500 Index
5. CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System
6. CareFusion Form 10 Registration Statement Declared Effective
7. CareFusion Expands Pyxis(R) Perioperative Solutions Offering
8. CareFusion Prices $1.4 Billion of Senior Notes
9. Cardinal Health Board of Directors Approves CareFusion Spinoff
10. CareFusion to Resume Shipping Alaris(R) Infusion Products
11. CareFusion Corporation Launches International Jazz Festival Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of ... the healthiest seniors are located in the Midwest. With the average cost of healthcare ... people are concerned with both the quality and affordability of where they live. An ...
(Date:5/26/2017)... ... ... After raising nearly $30,000 on Kickstarter , about three-times its original ... discounted crowdfunding price on Indiegogo . , “Along with creating an anti-stress gadget ... a fidget toy to the market that was made of superior quality and wouldn’t ...
(Date:5/26/2017)... ... 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in ... post on insurance options. If a Bay Area patient has to search for a ... money. Visiting an in-network provider for a second opinion can ensure a patient receives ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the stories ... Eden” is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist and ... NYC when she was three. At six, they moved to Dayton, Ohio, where Penny ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Understanind and choosing the most appropriate instruments for research and understanding the basic ... finding. This webinar will focus on innovations in stereo microscopy for brightfield and ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based in ... Parkinson,s disease (PD), has enrolled the first patient in the ... multicenter study involving patients with PD and taking place at ... 9-to-12-month period. The first stage is open label and involves ... include Denver , Boca Raton ...
(Date:5/10/2017)... , May 10, 2017  The Corporate ... or employees of sleep therapy clinics to call ... sleep therapy clinic is involved in a substantial ... interested in hearing from an employee of a ... in a kickback scheme to provide medical practice groups ...
(Date:5/9/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... on the development of oral drug delivery systems, ... has granted Oramed a patent titled, "Methods and ... covers Oramed,s invention of an oral glucagon-like peptide-1 ... hormone that stimulates the secretion of insulin from ...
Breaking Medicine Technology: